Cargando…
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977701/ https://www.ncbi.nlm.nih.gov/pubmed/36651980 http://dx.doi.org/10.1007/s00277-023-05083-y |
_version_ | 1784899353503072256 |
---|---|
author | Stanulla, Martin Schewe, Denis M. Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Eberl, Wolfgang Wolf, Saskia Wolf, Julian Vogiatzi, Fotini Bergmann, Anke K. Cario, Gunnar Beier, Rita Sauer, Martin Kratz, Christian P. Maecker-Kolhoff, Britta |
author_facet | Stanulla, Martin Schewe, Denis M. Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Eberl, Wolfgang Wolf, Saskia Wolf, Julian Vogiatzi, Fotini Bergmann, Anke K. Cario, Gunnar Beier, Rita Sauer, Martin Kratz, Christian P. Maecker-Kolhoff, Britta |
author_sort | Stanulla, Martin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9977701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-99777012023-03-03 Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia Stanulla, Martin Schewe, Denis M. Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Eberl, Wolfgang Wolf, Saskia Wolf, Julian Vogiatzi, Fotini Bergmann, Anke K. Cario, Gunnar Beier, Rita Sauer, Martin Kratz, Christian P. Maecker-Kolhoff, Britta Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2023-01-18 2023 /pmc/articles/PMC9977701/ /pubmed/36651980 http://dx.doi.org/10.1007/s00277-023-05083-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editor Stanulla, Martin Schewe, Denis M. Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Eberl, Wolfgang Wolf, Saskia Wolf, Julian Vogiatzi, Fotini Bergmann, Anke K. Cario, Gunnar Beier, Rita Sauer, Martin Kratz, Christian P. Maecker-Kolhoff, Britta Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia |
title | Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia |
title_full | Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia |
title_fullStr | Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia |
title_full_unstemmed | Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia |
title_short | Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia |
title_sort | molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977701/ https://www.ncbi.nlm.nih.gov/pubmed/36651980 http://dx.doi.org/10.1007/s00277-023-05083-y |
work_keys_str_mv | AT stanullamartin molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT schewedenism molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT bornhauserbeat molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT bourquinjeanpierre molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT eckertcornelia molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT eberlwolfgang molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT wolfsaskia molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT wolfjulian molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT vogiatzifotini molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT bergmannankek molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT cariogunnar molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT beierrita molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT sauermartin molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT kratzchristianp molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia AT maeckerkolhoffbritta molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia |